Delivery Order SPE2DB20D3505-SPE2DB23FU0V4

Award Date 5/4/23
Potential Completion Date 5/5/23
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. The contract has a ceiling value of $8,059.14 and a period of performance through August 6, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a large Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for Lidocaine 5% Patches, a specialty pharmaceutical product, with a ceiling value of $1,146.24 and a completion date of November 6, 2024. The contract has a firm fixed price pricing type and was not set aside for any specific business category. This delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Lidocaine 5% patches. The contract has a total ceiling value of $1,951.02 and a period of performance through August 26, 2024. This award is a firm fixed price contract and does not involve any set-aside designation. AmerisourceBergen is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the purchase of Lidocaine 5% patches. The contract has a ceiling value of $6,923.46 and runs through January 29, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, with a ceiling value of $2,215.95 and an ultimate completion date of May 9, 2023. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a medical supply item - specifically, Lidocaine 5% Patch 30s. The contract has a ceiling value of $1,535.12 and an ultimate completion date of May 8, 2023. The contract is a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% patches, with a ceiling value of $4,095.73 and a completion date of November 12, 2024. The contract type is Firm Fixed Price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565571289 Lidocaine 5% Patches. The contract has a ceiling value of $9,353.83 and a period of performance through August 27, 2024. AmerisourceBergen, a large pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,654.27 and a period of performance through January 25, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen, as the prime contractor, will be responsible for providing the medical products to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Lidocaine 5% patches. The contract has a ceiling value of $1,357.20 and a period of performance through August 9, 2024. The contract is a firm-fixed-price delivery order, which is a type of indefinite delivery contract that allows the government to efficiently procure these medical supplies on an as-needed basis. AmerisourceBergen, a major pharmaceutical...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB23FU0V4
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The Delivery Order has a Ceiling Value of $2,129.88 and a Period of Performance through May 5, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/9/25, 9:58 AM